Abstract
Cutaneous infections are a frequent cause of consultation in pediatric dermatology. Among them infection with the mollus cum contagiosum virus, tinea capitis, human papillomavirus and scabies are the most frequent today. In the treatment of molluscum contagiosum, there is still not enough evidence to support the different therapeutic options. The use of topical imiquimod is discarded within these options. In the systemic treatment of tinea capitis in the pediatric age, there is increasing evidence to support not only griseofulvin but also other drugs such as itraconazole, fluconazole or terbinafine. Adjuvant and contact treatment is highly recommended. New treatments against the human papillomavirus are available. Physical treatments due to their associated pain and the risk of sequelae are still considered second choice. Vaccination of both girls and boys is already included in the vaccination calendar in Spain. In the treatment of scabies, 5% permethrin cream remains the first choice, but new therapeutic options such as oral ivermectin have been incorporated into our therapeutic arsenal. In the following paper we carry out a review of the novelties in the treatment of these diseases.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2018 Boletín de Pediatría